UBS Maintains Buy on MetLife, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 72.1%

Neg 0% Neu 0% Pos 72.1%

UBS analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $105 to $110.

Comments

No comments yet. Be the first!